Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec 10;10(1):21633.
doi: 10.1038/s41598-020-78434-8.

Factors influencing therapy choice and clinical outcome in cerebral venous sinus thrombosis

Affiliations

Factors influencing therapy choice and clinical outcome in cerebral venous sinus thrombosis

Dagmar Krajíčková et al. Sci Rep. .

Abstract

We aimed was to assess the factors influencing therapy choice and clinical outcome after 3-4 months in patients with cerebral venous sinus thrombosis (CVST). In a retrospective, bi-centric study, the set consisted of 82 consecutive CVST patients (61 females; mean age 33.5 ± 15.7 years). Following data were collected: baseline characteristics, presence of gender-specific risk factors (GSRF), location and extent of venous sinus impairment, clinical presentation, type of treatment, recanalization, presence of parenchymal lesions, and clinical outcome after 3-4 months (assessed using the modified Rankin Scale [mRS], with excellent outcome defined as mRS 0-1). Multivariate logistic regression analysis was used for statistical evaluation. After 3-4 months, complete recovery was achieved in 41 (50%) and excellent clinical outcome in 67 (81.7%) patients. Female sex (OR 0.11; p = 0.0189) and presence of focal neurologic deficit (OR 0.16; p = 0.0165) were identified as significant independent negative predictors and, the presence of GSRF (OR 15.63; p = 0.0011) as significant independent positive predictor of excellent clinical outcome. In conclusion, in our CVST patients, the presence of GSRF was associated with excellent clinical outcome, while the female sex itself was associated with poorer clinical outcome.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

References

    1. Coutinho JM, Zuurbier SM, Aramideh M, Stam J. The incidence of cerebral venous thrombosis. A cross-sectional study. Stroke. 2012;43:3375–3377. doi: 10.1161/STROKEAHA.112.671453. - DOI - PubMed
    1. Einhäupl KM, et al. Heparin treatment in sinus venous thrombosis. Lancet. 1991;338:597–600. doi: 10.1016/0140-6736(91)90607-Q. - DOI - PubMed
    1. Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F, ISCVT Investigators Prognosis of cerebral vein and dural sinus thrombosis. Results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT) Stroke. 2004;35:664–670. doi: 10.1161/01.STR.0000117571.76197.26. - DOI - PubMed
    1. Haghighi AB, et al. Mortality of cerebral venous-sinus thrombosis in a large national sample. Stroke. 2012;43:262–264. doi: 10.1161/STROKEAHA.111.635664. - DOI - PubMed
    1. Kawaguchi T, et al. Classification of venous ischemia with MRI. J. Clin. Neurosci. 2001;8(Suppl 1):82–88. doi: 10.1054/jocn.2001.0884. - DOI - PubMed

Publication types